QSAM Biosciences (QSAM) 10-Q2021 Q1 Quarterly report

Filed: 21 May 21, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: abandonment, aka, anytime, ASU, bearing, biotechnology, California, cautionary, cautioned, chance, Christopher, clause, constituted, constituting, convincing, debenture, derived, discontinuance, discontinued, disease, disposal, disposed, disrupt, divested, duty, earnout, exit, fixed, flagship, government, healthcare, higher, history, hold, indefinite, intellectual, lump, Mach, mandated, match, met, mind, Nelson, noncurrent, outlook, par, paragraph, placement, ratio, reclassified, referenced, regulatory, reimbursement, reliance, requested, retrospective, slightly, spread, sum, target, terminology, undue, unvested, upcoming

Removed: accelerate, accuracy, acquire, addendum, Additionally, adequacy, adversely, alternate, alternative, annually, arranging, assessed, aware, Black, Bolin, bore, breakthrough, broker, cancelled, cashflow, CECO, codified, collectively, Community, comparable, compared, compete, competitive, concurrently, consented, consummated, consummation, cover, coverage, creating, decrease, demand, demographic, departure, diligence, distributorship, Eco, evenly, eventually, exchanged, exclusivity, extended, extension, facilitating, fail, financially, foreclose, grantee, guaranty, hired, hiring, historical, hope, identify, incurring, individual, infusion, insurance, integrate, inventor, joined, Kevin, licensor, life, litigation, load, loaned, longer, low, materialize, matured, meet, milestone, minimum, obligated, observer, operational, opportunity, penalty, percentage, PIK, producing, profitability, profitable, projected, proprietary, reached, Reform, relevant, repaid, repayment, repriced, retain, review, Richard, satisfied, seeking, sell, serve, served, short, simplified, solution, specific, Stewart, stronger, successfully, sustainable, tenure, tranche, Treasury, underlying, understanding, unforeseen, unit, vehicle, vice, visible, volume, VP, waived

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

QSAM similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q for QSAM Biosciences, Inc., (the “Company”) for the period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Douglas Baum, Chief Executive Officer and Thomas Knight, Chief Accounting Officer, of the Company certify pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002 that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 21, 2021

By:	/s/ Douglas Baum

	Chief Executive Officer

By:	/s/ Thomas Knight

	Chief Accounting Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.